This chemical is primarily used in organic synthesis as a key intermediate in the preparation of more complex molecules based on the 3,4-dihydroisoquinoline scaffold, particularly in pharmaceutical research. It serves as a building block for the development of compounds with potential biological activity, such as inhibitors or modulators of specific enzymes or receptors, including anticancer and anti-inflammatory agents. Its structure, featuring a bromo group at the 6-position and a tert-butyl carboxylate ester protecting group, allows for further functionalization through various chemical reactions, including cross-coupling reactions, nucleophilic substitutions, or reductions. This makes it valuable in the synthesis of heterocyclic compounds, which are often explored for their therapeutic properties. Additionally, it can be utilized in the study of structure-activity relationships (SAR) to optimize drug candidates for improved efficacy and selectivity, as well as in exploring new efficient synthetic methodologies.